Infections after organ transplantation and immune response

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Organ transplantation has provided another chance of survival for end-stage organ failure patients. Yet, transplant rejection is still a main challenging factor. Immunosuppressive drugs have been used to avoid rejection and suppress the immune response against allografts. Thus, immunosuppressants increase the risk of infection in immunocompromised organ transplant recipients. The infection risk reflects the relationship between the nature and severity of immunosuppression and infectious diseases. Furthermore, immunosuppressants show an immunological impact on the genetics of innate and adaptive immune responses. This effect usually reactivates the post-transplant infection in the donor and recipient tissues since T-cell activation has a substantial role in allograft rejection. Meanwhile, different infections have been found to activate the T-cells into CD4+ helper T-cell subset and CD8+ cytotoxic T-lymphocyte that affect the infection and the allograft. Therefore, the best management and preventive strategies of immunosuppression, antimicrobial prophylaxis, and intensive medical care are required for successful organ transplantation. This review addresses the activation of immune responses against different infections in immunocompromised individuals after organ transplantation.

Original languageEnglish
Article number101798
JournalTransplant Immunology
StatePublished - Apr 2023

Bibliographical note

Publisher Copyright:
© 2023


  • Immune response
  • Immunosuppressants
  • Infections
  • Organ transplant recipients


Dive into the research topics of 'Infections after organ transplantation and immune response'. Together they form a unique fingerprint.

Cite this